成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >API>Circulatory system drugs>Lipid regulating drugs>Rosuvastatin Calcium
Rosuvastatin Calcium
  • Rosuvastatin Calcium

Rosuvastatin Calcium NEW

Price Get Latest Price
Package 10gkg
Min. Order: 5gkg
Supply Ability: 1000kg
Update Time: 2023-09-26

Product Details

Product Name: Rosuvastatin Calcium CAS No.: 147098-20-2
Min. Order: 5gkg Purity: 99%
Supply Ability: 1000kg Release date: 2023/09/26

Adjunctive therapy for patients with primary hypercholesterolaemia (type IIa, including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type IIb) when diet or exercise therapy is unsatisfactory. (Lipid-lowering). Inhibits HMG-CoA reductase and reduces the synthesis and storage of cholesterol in hepatocytes, thereby lowering total cholesterol (TC) and LDL cholesterol in the blood.


Solemn promise:

Manufacturer production and shipment, guarantee quality and effect;

National free logistics, sent to all parts of the country;

100% damage replacement, invalid full refund;

Do a good job of product quality, enhance customer benefits.


Company Profile Introduction

  Shandong Fengjin Pharmaceutical Co., Ltd., a wholly-owned subsidiary invested by Shandong Fengjin Biopharmaceutical Co., Ltd., is mainly engaged in the research and development, production and sales of chemical APIs, and can undertake a variety of APIs and pharmaceutical intermediates CDMO business. The company was founded in March 2019 with registered capital of RMB 66 million and plans a total investment of RMB 620 million. The project covers a total area of 200,000 square meters and is planned to be completed in three phases. The first phase covers an area of 50,000 square meters and began to construct in February 2020. The main part of the first phase has been completed. The first phase project is expected to be completed in June 2023 and put into operation in July. The company’s current phase API products include febuxostat, rosuvastatin calcium, lenvatinib mesylate, sunitinib malate, sorafenib tosylate, erlotinib hydrochloride, etc.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$10.00/1KG
VIP6Y
Hebei Weibang Biotechnology Co., Ltd
2024-11-19
$35.00/25mg
VIP5Y
TargetMol Chemicals Inc.
2024-11-17
$0.00/1Kg/Bag
VIP4Y
Sinoway Industrial co., ltd.
2024-06-27
$0.00/1kg
VIP1Y
Shaanxi TNJONE Pharmaceutical Co., Ltd
2024-04-29
$50.00/1kg
Ouhuang Engineering Materials (Hubei) Co., Ltd
2024-04-24
$35.00/1kg
VIP1Y
Sigma Audley
2024-03-14
$0.00/1kg
Nanjing Fred Technology Co., Ltd
2024-01-04
$0.00/1kg
VIP5Y
Hebei Yanxi Chemical Co., Ltd.
2023-10-12
$0.00/25kg
VIP5Y
Hebei Mojin Biotechnology Co., Ltd
2023-08-17
$0.00/1KG
VIP2Y
Hangzhou ICH Biofarm Co., Ltd
2023-07-11
  • Since: 2019-03-07
  • Address: No.777 Jinnushan Road, Wuning Street, Muping District, Yantai City, Shandong Province, China
INQUIRY